固生堂(02273.HK)完成先舊後新配售股份 淨籌5.4億港元用作擴建線下醫療機構等
格隆匯3月30日丨固生堂(02273.HK)宣佈,配售事項及認購事項已分別於2023年3月24日及2023年3月30日完成。配售事項的所有條件均已獲達成而配售事項已於2023年3月24日完成。合共1040萬股銷售股份已由配售代理促成按每股銷售股份52.67港元之配售價成功配售予不少於六名承配人。
此外,認購事項的所有條件已獲達成而認購事項已於2023年3月30日完成。合共1040萬股認購股份(相等於根據配售事項配售的銷售股份數目)已由賣方按每股認購股份52.67港元的認購價認購,與配售價相同。認購股份相當於認購事項完成後經配發及發行認購股份擴大的公司已發行股本約4.32%。
公司自認購事項收取所得款項淨額合共約5.3961億港元。公司擬將所得款項淨額用作以下用途:(i)約60%或3.2377億港元用於擴建線下醫療機構,包括:(a)現有醫療機構的設施和設備的升級及翻新;(b)建立及收購新的醫療機構;(ii)約20%或1.0792億港元,用於升級及深化線上醫療平台的整合,加強集團線下及線上業務的聯繫及互動;(iii)約10%或5396萬港元用於豐富公司的產品組合,包括但不限於在合約研究機構的協助下開發院內製劑及建立內部製劑中心;及(iv)約10%或5396萬港元用於規範醫療解決方案及改善公司的信息技術系統。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.